Health Canada is warning consumers not to use Male Power Plus, a product used for erectile dysfunction that has not been authorized for sale in Canada. Male Power Plus was found to contain tadalafil, a substance not declared on the label. Those taking Male Power Plus are advised to stop consuming the product and to consult with their physician.
Tadalafil has been authorized by Health Canada as a prescription drug. Products containing tadalafil should be available only with a prescription written by a practitioner licensed to practice in Canada. The use of such a product may require a physical check-up, directions of use and on-going monitoring by a physician.
Consumption of this product could affect individuals who are using nitrates (medication for heart disease such as angina) or have health conditions such as uncontrolled arrhythmias, hypotension, uncontrolled hypertension, stroke and severe renal or hepatic insufficiency. Nitrate medications are commonly used to treat some types of heart disease such as angina. Concurrent nitrate and tadalafil use could result in the development of potentially life-threatening low blood pressure. In extremely rare instances, use of tadalafil may potentially result in penile tissue damage and permanent loss of potency.
Male Power Plus, which lists Spectrum Partners Inc. on the label, is sold in capsule form and contains two capsules per pouch. The product is imported by Erofun Import and S.D. Variations in Canada. Health Canada has taken steps to confirm the product is removed from the Canadian market.